Digital Intervention for Suicide Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a smartphone app called ViraBrite, designed to prevent suicide by engaging users with safety planning and coping skills during distress. The goal is to determine if sending nudges at various times of the day can improve user interaction with the app. Participants who have recently experienced suicidal thoughts or actions and can use a smartphone daily might be a good fit for this trial.
As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance mental health support through technology.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a smartphone app for suicide prevention, so it's likely you can continue your medications, but you should confirm with the trial organizers.
What prior data suggests that the ViraBrite app is safe for users?
Research has shown that the BRITE suicide safety planning app, on which ViraBrite is based, effectively reduces future suicide attempts among young people hospitalized for such attempts. This suggests the app can be a useful tool for managing emotional distress and promoting safety.
Studies using similar smartphone-based tools for suicide prevention have not reported any major negative effects. These digital tools generally help users learn coping skills and manage their emotions, which are important for preventing suicide.
ViraBrite improves upon BRITE by building on these successful features. The app is designed for ease of use and aims to support users during times of high emotional distress. While specific safety data for ViraBrite is not yet available, the success of the BRITE app indicates its potential safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about ViraBrite because it offers a novel digital approach to suicide prevention. Unlike traditional therapies, which often rely on in-person counseling or medication, ViraBrite uses a smartphone app to deliver timely nudges that encourage users to engage in coping and safety planning skills. This method provides continuous support and intervention opportunities, tailored to individual needs throughout the day. Additionally, the randomized timing of notifications ensures that users receive prompts at varied times, making the intervention more dynamic and potentially more effective in real-time crisis management.
What evidence suggests that the ViraBrite app is effective for suicide prevention?
Research has shown that digital tools can help reduce suicidal thoughts and behaviors. In this trial, participants will use the ViraBrite app, which studies indicate helps people engage with coping strategies and safety plans. These digital tools provide timely support during high-risk periods. Reviews have found these interventions helpful for people of different ages and genders. Overall, evidence supports that digital methods like ViraBrite can effectively prevent suicide.678910
Are You a Good Fit for This Trial?
This trial is for adolescents struggling with mental health issues, including thoughts of suicide or anhedonia (inability to feel pleasure). Participants should be comfortable using a smartphone app designed to help with suicide safety planning. There are specific inclusion and exclusion criteria not detailed here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage with the ViraBrite app, receiving daily nudges to utilize coping and suicide safety planning skills
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ViraBrite
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ksana Health
Lead Sponsor
University of Pittsburgh Medical Center
Collaborator
National Institute of Mental Health (NIMH)
Collaborator